EDIOS THERAPEUTICS PARTNERS WITH WESTWOOD & WILSHIRE TO FILL EXECUTIVE MEDICAL DIRECTOR

Eidos Therapeutics, a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, has hired Rebecca Vanlandingham as Executive Medical Director. Dr. Vanlandingham  joins Eidos from Teva Pharmaceuticals, where she served in a similar capacity as Director of Clinical Development. Prior to Teva, Dr. Vanlandingham led her own private practice as an Immunologist. 

The search was successfully led by Gerard Danishek for Westwood & Wilshire’s Life Sciences practice.

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.